Being a Shareholder
As a Sanofi shareholder, you own a share in our capital, providing us with the resources we need to grow. By investing in our future, you are giving us a vote of confidence. Confidence is the cornerstone of the special relationship between us and our shareholders. We are committed to retaining and building your confidence by involving you in our development and giving you a share of our profits.
Q2 2024 Financial Results
“We are continuing our strong performance in 2024 and delivered broad-based, double-digit sales growth in the second quarter. We also made important progress in our pipeline of new medicines, including approvals for Dupixent in COPD, Kevzara in pediatric arthritis and ALTUVIIIO (EU) in hemophilia A. With the EU approval in COPD, Dupixent is the first-ever biologic medicine approved in this debilitating disease impacting hundreds of thousands of patients globally. As we accelerate our focused mid- and late-stage pipeline, we started a number of new phase 2 and phase 3 studies that will benefit patients in the future. We are well on track, delivering on our strategic priorities for Sanofi to become a development-driven, tech-powered biopharma company committed to serving patients and accelerating growth. Underpinned by accelerated delivery of Sanofi’s transformation, we upgrade our earnings per share guidance for 2024.”
Paul Hudson, Chief Executive Officer
Our Pipeline
5
78
29
Sanofi France – Key figures
How to Hold Sanofi Shares
Sanofi ordinary shares can be held as:
- Bearer shares: deposited with your financial intermediary,
- Administered registered shares: deposited with your financial intermediary and recorded in the books of Sanofi,
- Fully registered shares: deposited with and administered by Uptevia, transfer agent appointed by Sanofi. You benefit in this case from preferential rates for brokerage fees & bank commission and double voting rights when you have held your shares for at least two years
Buying Shares
To buy or sell Sanofi shares, you must place an order with your financial intermediary or with Uptevia. Your request should be as clear as possible and include the following details:
Company name: Sanofi
o Euronext Paris: SAN
o Nasdaq: SNY
ISIN code: FR0000120578
Bearer or Administered Shareholder
Contact your financial intermediary, if you want to record your shares as “bearer” or “administered registered” shares. You will have to open a securities account to place stock market orders.
Contact Uptevia, our transfer agent, if you want to record your shares as “fully registered shares”.
Forms to fill-in and to send to Uptevia:
Fully Registered Shareholder
Contact Uptevia, our transfer agent, if you want to buy your shares as “fully registered shares”.
Forms to fill-in and to send to Uptevia:
Uptevia fees for holding pure registered securities:
- Free custody and administration fees
- Bank commission of 7.62 euros per order
- Brokerage fee: 0.45% with a minimum of 6.10 euros per order
Frequently Asked Questions From Individual Shareholders
In-Depth Reading
Shares
